Free Trial

Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Short Interest Up 1,560.2% in August

Reckitt Benckiser Group logo with Consumer Staples background

Reckitt Benckiser Group plc (OTCMKTS:RBGLY - Get Free Report) saw a large increase in short interest in August. As of August 31st, there was short interest totalling 212,500 shares, an increase of 1,560.2% from the August 15th total of 12,800 shares. Based on an average daily volume of 735,300 shares, the short-interest ratio is presently 0.3 days.

Reckitt Benckiser Group Price Performance

Shares of RBGLY stock traded up $0.02 during trading hours on Thursday, hitting $12.08. 303,579 shares of the company's stock traded hands, compared to its average volume of 897,823. The stock's 50 day simple moving average is $11.25 and its 200 day simple moving average is $11.40. Reckitt Benckiser Group has a 12 month low of $10.24 and a 12 month high of $15.03.

Reckitt Benckiser Group Cuts Dividend

The business also recently announced a dividend, which will be paid on Monday, September 23rd. Investors of record on Monday, August 5th will be given a dividend of $0.1915 per share. The ex-dividend date is Monday, August 5th.

Analyst Ratings Changes

Separately, JPMorgan Chase & Co. cut shares of Reckitt Benckiser Group from an "overweight" rating to a "neutral" rating in a research note on Thursday, August 29th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, Reckitt Benckiser Group has an average rating of "Hold" and a consensus price target of $7,400.00.

Check Out Our Latest Analysis on RBGLY


Reckitt Benckiser Group Company Profile

(Get Free Report)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Recommended Stories

Should you invest $1,000 in Reckitt Benckiser Group right now?

Before you consider Reckitt Benckiser Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.

While Reckitt Benckiser Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Is Palantir Heading for a $50 Price Target?
Rate Cuts Fuel Volatility: How Long Could it Last?
SMCI Stock: Is a Rebound Coming?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines